Investors Are Panic Selling AAVE for VC Spectra (SPCT) And Hedera (HBAR) – Here’s Why It Makes Sense
If you’re going to zoom out on the daily chart of AAVE, you can’t help but think that its best days are already behind it. On the other hand, Hedera completed integrating its proof-of-concept (PoC) trial for stablecoin remittances. Meanwhile, VC Spectra (SPCT) delights investors and speculators with its high-reward and low-risk potential after securing $2.4 million from its private seed sale.
Naturally, curious eyes focus more on Hedera (HBAR) and VC Spectra (SPCT) than AAVE. Let’s find out why!
Should You Buy the Dips of AAVE or Err on the Side of Caution?
AAVE launched GHO, its newest stablecoin, and was traded on Ethereum on July 18, 2023. Although nearly $2.5 million GHO coins have been created in less than 48 hours, crypto traders and investors manifested a bearish sentiment. AAVE dropped by 4.10% from its closing price of $75.1 per token on July 17 to its closing price of $72.02 per token the next day.
If you think that’s the bad news for the day, wait until you discover that AAVE is down by 89.20% from its all-time high of $666.86, registered two years ago. Plain logic will tell you that holding your position on AAVE from the first quarter of 2021 to today is not an intelligent investor’s move.
Doing dollar-cost averaging in a token on a free fall will only empty your wallet. The trailing stop of those who entered a position on AAVE during the early part of 2021 must have already sold their position by now.
What Makes VC Spectra (SPCT) A Spectacular Investment Option?
“Should I invest in the presale of a token or not?”
That is an evergreen question many crypto enthusiasts ask. Why crypto investors are skeptical about buying a token’s public presale is understandable. VC Spectra (SPCT) proactively addresses this concern by highlighting sustainability and transparency as advantages compared to its peers in the industry, according to its whitepaper.
VC Spectra (SPCT) was priced at $0.008 per token during Stage 1. Its Stage 2 started on July 19, 2023, for $0.011 per token. If you invested in VC Spectra (SPCT) during Stage 1, your investment would have easily grown by 37.50% during Stage 2.
Stage 3 of VC Spectra (SPCT) offers a more lucrative opportunity as it will be priced at $0.025, a 127.27% surge.
Is investing in the public presale of VC Spectra (SPCT) worth it? The basic Arithmetic we just did gives a crystal-clear answer. Let’s determine if Hedera (HBAR) is a strong contender.
How Has the Latest News on Hedera (HBAR) Affected Its Price Trend?
The first successful stablecoin transaction proof-of-concept conducted by Shinhan Bank and SCB TechX through Hedera (HBAR) is believed to have solved the problems in cross-border transactions. Reports reveal that the integration enabled real-time settlement and FX rate integration across three currencies – Thai Baht, New Taiwan Dollar, and the South Korean Won.
Moreover, the market translated this recent Hedera (HBAR) development with positive sentiment. With a closing price of $0.05193 on Monday and a prevailing price of $0.05889 per token, Hedera (HBAR) has advanced by 13.40%.
On the other hand, Hedera (HBAR) is still trapped in the bears’ pit as HBAR plummeted by over 40% from its intra-year high of $0.09862. This makes VC Spectra (SPCT) a more lucrative investment option over Hedera (HBAR) and AAVE.
Learn more about the VC Spectra (SPCT) presale:
Disclaimer and Risk Warning
The content featured on Coinpedia's press release page is provided for informational purposes only. Coinpedia does not endorse, verify, or take responsibility for the accuracy, completeness, or reliability of any press releases or associated materials. Any views, opinions, or statements expressed in these press releases are those of the respective issuers and do not reflect the opinions or positions of Coinpedia. Coinpedia is not liable for any content, products, services, or actions mentioned in the press releases. Readers should independently verify the information before taking any actions related to the subject matter of the releases.